Breakthrough in Brain Tumor Research-VORTIOXETINE

27 NOV

Published on November 27, 2024 by pharmaffiliates

Understanding Elobixibat: A New Chapter In The Fight Against Chronic Constipation

In recent years, there has been a surge of interest in finding effective treatments for chronic constipation and irritable bowel syndrome with constipation (IBS-C)—two conditions that affect millions of people worldwide.
Read More

16 October

Published on October 16, 2024 by pharmaffiliates

Breakthrough in Brain Tumor Research-VORTIOXETINE

Recent advancements in brain tumor research have illuminated the potential of VORTIOXETINE a well-known antidepressant, in the context of neuro-oncology.
Read More

Get ready to connect and innovate! 📅 Join us at CPHI INDIA 2024

11 October

Published on October 11, 2024 by pharmaffiliates

Get ready to connect and innovate! 📅 Join us at CPHI INDIA 2024!

We are thrilled to announce that Pharmaffiliates will be participating in the esteemed CPHI India 2024 Exhibition! This renowned international event serves as a premier platform for innovation, networking and collaboration among industry leaders in the pharmaceutical sector.
Read More

Mark your calendars!! Delighted to announce our participation at CPHI, Milan 2024

16 SEP

Published on September 16, 2024 by pharmaffiliates

Mark your calendars!! Delighted to announce our participation at CPHI, Milan 2024

We're excited to announce that Pharmaffiliates will be participating in the prestigious CPHI, Milan 2024 Exhibition! This international event is a hub for innovation, networking, and industry leaders.
Read More

Pharmaffiliates-A Perfect Outsourcing Partner

06 August

Published on August06, 2024 by pharmaffiliates

Pharmaffiliates is Exhibiting at Arablab 2024!

Pharmaffiliates is thrilled to announce our participation at the prestigious Arab Lab 2024, taking place at the Dubai World Trade Centre from September 24th to 26th.
Read More

08-10 September

Published on September08-10, 2024 by pharmaffiliates

Excited to announce our participation at Pharmaconex CPHI Egypt!

Pharmaffiliates is thrilled to announce our participation at the Pharmaconex CPHI Egypt, taking place at the Egypt International Exhibition Center in Cairo, Egypt from September 08-10, 2024.
Read More

23 May

Published on May23, 2022 by pharmaffiliates

Spotlight video on ICP analytical instruments

04 January

Published on January04, 2022 by pharmaffiliates

Desperate hunt of Anti-Virals for COVID-19 cure

It is rightly said 'Desperate Times Call for Desperate Measures'
As cases from the coronavirusare relentlessly mounting into hundreds and thousands again
Read More

24 August

Published on August24, 2021 by pharmaffiliates

Pharmaffiliates - A Perfect Outsourcing Partner

CRAMS or Contract Research and Manufacturing Services, which is the newest, fastest growing and the most sought after segment in Pharmaceutical world.
Read More

Pharmaffiliates - Leading the way for Research

24 July

Published on July24, 2021 by pharmaffiliates

Pharmaffiliates - Leading the way for Research

Stable isotope labeling includes the use of non-radioactive isotopes which can serve as tracers that are used to track different .....
Read More

18 Sep

Published on Sep18, 2020 by pharmaffiliates

Tenofovir - A Wonder Drug For Covid -19

As the coronavirus pandemic swept through major part of the world in 2020, the US Food and Drug Administration has approved antiviral .....
Read More

Quetiapine - Atypical Antipsychotic Drug

7 Aug

Published on Aug7, 2020 by pharmaffiliates

Quetiapine - Atypical Antipsychotic Drug

An atypical antipsychotic, Quetiapine is a dibenzothiazepine derivative which is available in different pharmaceutical forms. .....
Read More

Lopinavir/Ritonavir - A Promising Co-Formulated Drug

17 Jun

Published on Jun17, 2020 by pharmaffiliates

Lopinavir/Ritonavir- A promising co-formulated drug

End of December 2019 and beginning of the year 2020 marked the emergence of, a novel coronavirus, designated SARS-CoV-2, and has caused an international .....
Read More

02 Jun

Published on Jun 02, 2020 by pharmaffiliates

Remdesivir – A new “standard of care” against COVID 19

Fauci, the director of the National Institute of Allergy and Infectious Diseases, announced in an unpublished from a phase 3 trial that showed Remdesivir .....
Read More

Chloroquine And Hydroxychloroquine - A Ray Of Hope

01 April

Published on April 01, 2020 by pharmaffiliates

Chloroquine And Hydroxychloroquine - A Ray Of Hope

It is evident; there are no specific drugs for COVID-19. Scientists and researchers around the globe are leaving no stone unturned to find a cure for.....
Read More

Ondansetron- A globally accepted Antiemetic drug

04 March

Published on March 04, 2020 by pharmaffiliates

Ondansetron- A Globally Accepted Antiemetic Drug

A recent report by Medspace suggests that Acute Gastroenteritis is responsible for some 600,000 hospitalizations and 5000 deaths a year in the.....
Read More

Olmesartan – A NDMA Free Drug Declared By FDA

22 Feb

Published on Feb 22, 2020 by pharmaffiliates

Olmesartan – A NDMA Free Drug Declared By FDA

Over 350 million people in the world currently are suffering from Diabetes mellitus (DM) which is a major metabolic disorder that is prevalent in both developed and developing.....
Read More

Coronavirus (2019-nCoV) Treatment - Atazanavir A Ray Of Hope

13 Feb

Published on Feb 13, 2020 by pharmaffiliates

CORONAVIRUS (2019-nCoV) TREATMENT-ATAZANAVIR a Ray of Hope

For centuries, the world has time and again come under the grip of epidemics which wipe out a major portion of civilization. And by the time scientific and medicinal fraternity .....
Read More

Temozolomide - A Miracle For Glioblastoma (GBM) Patients

31 Jan

Published on Jan 31, 2020 by pharmaffiliates

Temozolomide- A miracle for glioblastoma (GBM) patients

Studies indicate, that nearly 5–8/100,000 population suffer from Malignant gliomas (glioblastoma multiforme and anaplastic astrocytoma) which occurs more.....
Read More

Levetiracetam-A Novel AED And Monotherapy Drug

09 Jan

Published on Jan 9, 2020 by pharmaffiliates

Levetiracetam-A Novel AED and monotherapy drug

In World's neurological disorder burden, Epilepsy has termed the fourth common disease after headache, migraine and Alzheimer's disease. .....
Read More

25 Dec

Published on Dec 25, 2019 by pharmaffiliates

Meloxicam- An NSAID with a difference

After surgery, post-operative pain is an expected consequence. Opioid analgesics are although used as primary therapy there are many adverse side effects .....
Read More